The case emphasizes Bannwarth syndrome as a rare but treatable cause of neurologic deterioration in an older woman receiving surgical cancer care.
Consider a patient with abdominal pain or fever of unknown origin. The presentation may not scream catastrophe. The vital ...
Halozyme Therapeutics, Inc. ("Halozyme") today announced that Dr. Helen Torley, President and Chief Executive Officer, is ...
Kivu Bioscience, Inc., a clinical-stage biotechnology company developing next-generation antibody-drug conjugates (ADCs) for difficult-to-treat cancers, today announced the presentation of new ...
Researchers from our Computer Science Department have created new artificial intelligence (AI) tools that could help doctors ...
A "healthy, vibrant" young woman tragically died after suffering from a rare condition. Mia Thomas was just 23 years old when she died on September 7 last year. Her family described Mia as a fit and ...
Key points A 4-year-old boy presented to our urgent ophthalmology clinic for photophobia and persistent eye rubbing. He had been born at 39 weeks via Cesarean delivery, without complications. Prenatal ...
The inquest into the death of a mum who died from suspected rabies after being scratched by a dog in Morocco. Yvonne Ford, 59, had died weeks after being scratched by a puppy while on holiday last ...
A "healthy, vibrant" young woman tragically died after suffering from a rare condition. Mia Thomas was just 23 years old when she died on September 7 last year. Her family described Mia as a fit and ...
Peripheral T-cell lymphoma, not otherwise specified (PTCL-NOS), is a rare subtype of non-Hodgkin lymphoma that frequently presents with multiorgan involvement. We report a diagnostically challenging ...
PRIMETIMER on MSN
The Pitt treated Louie’s ascites like the main problem until a pulmonary hemorrhage rewrote the episode
Louie’s ascites was treated in The Pitt until a pulmonary hemorrhage linked to liver failure caused sudden death, shifting the episode’s focus to emergency response and complications.
Declares a regular quarterly cash dividend of $0.20 per share of common stock for the fourth quarter of 2025, payable on March 6, 2026.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results